5PSQ-062 单药治疗 pembrolizumab 的安全性评估

{"title":"5PSQ-062 单药治疗 pembrolizumab 的安全性评估","authors":"A. Almanchel Rivadeneyra, J. González Bartolomé, MI Castillo Medrano, R. Fernández Galán, LC Fernández Lisón","doi":"10.1136/ejhpharm-2024-eahp.396","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":107680,"journal":{"name":"Section 5: Patient safety and quality assurance","volume":"91 9","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"5PSQ-062 Safety evaluation of pembrolizumab in monotherapy\",\"authors\":\"A. Almanchel Rivadeneyra, J. González Bartolomé, MI Castillo Medrano, R. Fernández Galán, LC Fernández Lisón\",\"doi\":\"10.1136/ejhpharm-2024-eahp.396\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":107680,\"journal\":{\"name\":\"Section 5: Patient safety and quality assurance\",\"volume\":\"91 9\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Section 5: Patient safety and quality assurance\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1136/ejhpharm-2024-eahp.396\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Section 5: Patient safety and quality assurance","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/ejhpharm-2024-eahp.396","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}